The rapid rise of GLP-1 prescription medications is reshaping the weight management landscape, but it is not eliminating the role of nutrition, physical activity, and non-prescription wellness products, according to Scotland-based consumer wellness company Wolfson Group. A June 2026 report from PwC shows that 21% of U.S. households included a current GLP-1 user as of May 2026, up from 9% in January 2025. That surge has brought renewed attention to weight management, but Wolfson Group argues that consumers are navigating a diverse marketplace that still includes nutritional products, fitness programs, and non-prescription brands.
The company participates in the non-prescription category through PhenQ, an established wellness brand available to U.S. consumers through Amazon and, more recently, OneLavi.com. The company stresses that PhenQ is not a substitute for prescribed medical treatments and that the two categories are distinct. Still, it believes non-prescription products have an important place in everyday routines.
“The weight management market is evolving, and consumers have more choices than ever before,” said the founder and CEO of Wolfson Group. “Prescription medications have become an important part of the conversation, but nutrition, physical activity and everyday lifestyle habits remain central to how people think about managing their weight. Our focus is on serving consumers in the non-prescription wellness market.”
The implications extend beyond one brand. As GLP-1 use grows, the market is segmenting into prescription and non-prescription tiers, creating opportunities for consumer education about intended uses and informed decision-making. Wolfson Group is expanding U.S. distribution for PhenQ, including its recent availability through OneLavi.com, as part of a broader strategy to develop multiple channels. The company also highlighted its portfolio of wellness brands, including PhenQ, TestoPrime, NooCube and YourBiology, spanning weight management, cognitive wellness, gut health, and men’s wellbeing. Wolfson Group continues to pursue additional U.S. retail opportunities following its participation in the September ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida. The company said it will continue investing in consumer education, science-led brand development, and expanded U.S. distribution as it builds its presence across the American wellness marketplace.

